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In  order  to  locate  the  promoter  region  of  the  human 
terminal  deoxynucleotidyl  transferase  gene,  serially 
truncated  segments  of  the  B’-flanking  region  of  the  gene 
were cloned into a chloramphenicol acetyltransferase 
reporter  vector.  Transient  transfection  analyses  of  the 
terminal transferase-reporter gene constructs identi- 
fied  the  basal  promoter  region  within  -34  to  +40  base 
pairs  relative  to  the  transcription  start site. Three  pro- 
moter  elements  were  defined  in  this  region.  The  primary 
element is within 34 base  pairs  upstream  of  the  tran- 
scription  start site. The CAP site  is 62 base pairs up- 
stream  of  the  translation  start site. The  secondary ele- 
ment  involves  sequences  around  the  transcription  start 
site. The  third is located 25 base  pairs  downstream  from 
the  initiation  site (+25 to  +40).  This  tripartite  basal  pro- 
moter  was  not tissue  specific;  similar  patterns of  pro- 
moter activity were observed in terminal transferase 
expressing  and  non-expressing  cells.  Transfection 
analyses  also  indicated  the  presence of negative  regula- 
tory  elements  upstream  of  the  basal  promoter  region, 
and  these  elements  were  preferentially  active  in  cells 
expressing  terminal  transferase. 
Immunoglobulin (Ig) and T-cell receptor gene assembly is 
attained through gene rearrangement of a large number of 
separately coded variable (V), diversity (Dl, and joining (J) 
gene  segments  (Ikuta et al., 1992). I t  is well known that  the 
diversity of the  immune  repertoire is greatly  increased by the 
addition of nucleotides (N regions) at the  D/J  and VLDJ junc- 
tions  during  Ig  and T-cell receptor  gene  rearrangements (Desi- 
derio et  al . ,  1984; Schatz  and  Baltimore, 1988). Terminal de- 
oxynucleotidyl transferase  (TdT),l a template-independent 
DNA polymerase,  that  randomly polymerizes deoxyribonucleo- 
side  triphosphates onto initiator DNAs (Bollum,  1974) has  been 
shown to be the only enzyme involved in N region addition 
(Komori et   al . ,  1993;  Gilfillan et  al . ,  1993). Although we under- 
stand  the biochemistry and role of this enzyme, little  is  known 
about  the expression of the TdT gene. TdT expression is  re- 
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stricted  to prelymphocytes at a specific stage of differentiation 
and  during  gene  rearrangements (Deibel et  al.,  1983). Study of 
this gene provides us  with  an excellent opportunity  to  under- 
stand  both  the  activation  and  repression of gene transcription. 
We have  thus  undertaken  the  analysis of the  regulation of the 
human  TdT gene. 
Regulation of transcription  initiation is an important mecha- 
nism for control of gene expression. Most eukaryotic  promoters 
contain a TATA box which is usually located 25-30 nucleotides 
upstream of the transcription initiation site (Sawadogo and 
Sentenac, 1990). A TATA-binding protein  binds  to this TATA 
motif, (Roeder, 1991)  and  along  with RNA polymerase I1 and 
other  additional  factors  directs  the precise  location of the  tran- 
scription  initiation  site  (Nakajima et al . ,  1988; Pugh  and  Tjian, 
1992). Besides these TATA-containing genes  there  are  numer- 
ous  other  genes  transcribed by RNA polymerase I1 that lack  a 
TATA box upstream of the  transcription  start  site (Weis and 
Reinberg,  1992).  A number of studies  have revealed that sev- 
eral of the TATA-less genes  contain a DNA sequence (termed 
the  initiator  element or Inr)  that encompasses the  transcrip- 
tion start site, and is responsible for specifying the precise 
initiation site for transcription (Zenzie-Gregory et a l . ,  1992; 
Weis and Reinberg, 1992). In TATA-less promoters  the  Inr el- 
ement plays an  important role in  the correct  positioning of RNA 
polymerase 11. The  murine  TdT  gene, which lacks a TATA  box 
and  binding  sites for common transcription factors, like Spl, 
contains an  Inr  element  that  is responsible  for the  basal  tran- 
scription of the gene. (Smale  and  Baltimore, 1989). The  human 
TdT gene also lacks a consensus TATA box, but  visual inspec- 
tion of the 5’ proximal sequences of the  gene failed to locate an 
obvious Inr  element. 
The 5’ upstream sequences of human and mouse TdT do 
share some homology. Alignment of the 5’ sequences of the 
human  and mouse  TdT genes  revealed 72% homology within a 
region  corresponding to -186 to +51 bp  in  the mouse  gene when 
three  insertions of 9,20,  and 27 bp of the  human sequence were 
excluded (Lo et  al . ,  1991). Interestingly,  our  study shows that 
the 27-bp insertion corresponds  precisely to the position of the 
transcription start site of the  human gene  identified in vivo. 
The  limited homology between the 5’ sequences of the  murine 
and  the  human  TdT  genes coupled with  the  apparent absence 
of a  mouse Inr  element homolog suggested  that  the mouse and 
the  human  TdT  genes employed different  promoter  elements. 
Our goal was  to  study  the 5‘ sequences in  detail  and to identify 
control elements  participating  in  human TdT gene  regulation. 
We have  demonstrated that transcription of the  human TdT 
gene initiated at a single nucleotide. Transient transfection 
analyses of the  human  TdT  gene  promoter region identified 
three  requisite  elements located upstream of the  start  site,  at 
the  start  site  and  interestingly,  downstream of the  start  site 
that  were necessary for correct initiation  and optimal promoter 
activity. 
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MATERIALS AND METHODS 
Cell Lines-The cells  used in this study  were  established cell lines of 
leukemia-lymphoma  origin and  were  found  to  represent  different,  early 
stages of lymphocyte maturation (Drexler et al., 1985). The human 
lymphoid cell lines KT-1,  MOLT-4, (pre-T), NALM-6 (pre-B)  which ex- 
pressed  TdT  and KOPN-8 (pre-B),  KE-37  (mature-T  cells) that  did  not 
expressed TdT were used. The cells were maintained in RPMI-1640 
media  supplemented  with 10% fetal bovine serum  (Trangas  and 
Coleman, 1989). 
Isolation of RNA and 5"RACE-RNA was  isolated  from  cells by gua- 
nidine  isothiocyanate cell lysis and  centrifugation  through CsCl cush- 
ions  (Sambrook et al., 1989). 5'-RACE reactions  were as described by 
Bethesda  Research  Laboratories. cDNA was  synthesized  using  2 pmol of 
antisense  primer  (RACE5 or RACE4-, see below) and 1 pg of total RNA. 
After  RNase  digestion the cDNA was  isolated  and  incubated  with  TdT 
and 200 p~ dCTP. Five pl of the cDNA containing  the  added  dC  sequences 
was  amplified by PCR  using  20 pmol of both  the  appropriate  internal 
antisense  primer  and BRL anchor  primer  in a volume of 50 pl. PCR 
products  were  separated  on  an  agarose  gel  and  were sized by comparison 
with  the  migration of HincII-digested $X174  DNA markers (BRL). The 
primers used for cDNA synthesis were 5'"lTGTGAGCTGACTTGT- 
ACTTTCTGTG-3' (RACE5-, exon-2 sequences)  and 5'-CCGAACCC- 
GAG'ITGTTCTCTGCTAC-3' (RACE4-, exon-2 sequences upstream of 
RACE5-). The  internal  primers for PCR were 5'-CATTTTCAACCCT- 
GAACCC'WI'CC-3' (RACE3-, exon-1  sequences), 5"GAAATTTGAT- 
GTCTTGAGGAGAGGAGGCC-3' (225, exon-1  sequences  upstream of 
exon-1  sequences  upstream of RACE3-) and RACE4-. The oligonucle- 
otides  were  synthesized at the  University of North  Carolina  Chapel  Hill, 
Lineberger  Comprehensive  Cancer  Center  using an  Applied Biosystems 
394  Synthesizer. All primers  were  complementary  to human  TdT mRNA 
sequences (Riley et ai., 1988) except the BRL  anchor primer. 
Construction of TdTCAT Plasmids-The -93OCAT DNA was con- 
structed by first  subcloning a 995-bp  BamHI  fragment of the 5' non- 
coding region of the  human  TdT  (995  bp  upstream of the ATG) into  the 
BamHI  site of pUCI3. pUCI3 is a pUC-based plasmid in which the 
multiple cloning site  has  been modified in  our  laboratory  to  facilitate 
the subcloning of 5"flanking regions of human TdT. A HzndIIIIPstI 
fragment from pUCI3  containing  the  995  bp of TdT  was then subcloned 
into  the  HindIIIIPstI  site of pCAT-Enhancer (Promega)  to  produce  the 
-93OCAT DNA. The  numbering for the vectors  corresponds  to the dis- 
tance  in  base  pairs  upstream  or  downstream from the  TdT  transcription 
start site. The vectors containing -656CAT and -356CAT were con- 
structed  similarly,  except that a BamHIIEcoRI  or  a BamHI/AceI frag- 
ment  (721 or 421  bp  upstream of the ATG) was cloned into  the  BamHY 
EcoRI or BamHIIAccI site of PUCI3.  The -286CAT,  -202CAT,  -54CAT, 
-34CAT, -5CAT, +25CAT, +41CAT, and -54 to +25CAT vectors  were 
constructed by amplifying the appropriate region by using the po- 
lymerase  chain  reaction  and  then  subcloning  the DNA fragments. Oli- 
gonucleotide  primers  (Fig.  2)  which  contained a Hind111 site  in  the 5' 
primers  and  PstI  site  in  the  3'  primers  were  used  in  the  reactions.  The 
amplified  products  were then subcloned  into  the  HindIIIIPstI  sites of 
pCAT-Enhancer. For  the  constructs -286CAT, -202CAT, and -54CAT, 
the  reverse  primer  used  was  R1  which  encompasses  the  translational 
start site.  The  reverse  primer R2 was  used for making  the  constructs 
-34CAT,  -5CAT,  +25CAT and +41CAT. These  constructs  included 55 bp 
of exon-1. R3  was  used  as  the  reverse  primer  to  make -54 to  +25 CAT. 
The -286CAT(R) DNA (-286 bp  upstream of  ATG in  the  reverse  orien- 
tation)  was  made by first isolating  the  fragment from -286CAT  DNA. 
The  isolated  fragment  was cloned by blunt-end  ligation  into  the SmaI 
site of pUCI3. A clone with the  fragment  in  the  reverse  orientation 
(determined by DNAsequencing)  was then digested by HindIIYPstI  and 
subcloned  into the HindIIIIPstI  site of pCAT-Enhancer. The exon-1CAT 
DNA was  made  in  a way similar to -286CAT(R) except that  a  BarnHIl 
AuaI  fragment  containing  exon-1 of TdT  was subcloned into  the  SmaI 
site of pUCI3. All plasmid  constructs  were  analyzed by dideoxy sequenc- 
ing  (U. S. Biochemical Corp. sequencing kit) and  purified by polyethyl- 
ene glycol precipitation followed by cesium  chloride  gradient  centrifu- 
gation. 
DNA Zhnsfection-For DNA transfection  experiments,  cells  in log 
phase at  a density  between 5 x 105t0  6 x lo5 were  used.  Harvested cells 
were  pelleted,  washed, and  suspended  in  a volume of lo7 cells/300 pl of 
phosphate-buffered  saline + 7.5% fetal bovine serum  (Matsushima  et 
al., 1992).  For  each  transfection,  35  pg of the CAT plasmid  to  be  tested 
and 5 pg of the plasmid pCMVp (coding  for  0-galactosidase  activity) in  
a  volume  not  exceeding  20  pl  were  added  to  300 pl of cell suspension  in 
a  gene  pulser  electroporator  cuvette (Bio-Rad). The  cells  were  immedi- 
RACE3-), 5'-GGTCTCTTCTTCCGAGGGCTCAAGTGGGAC-3' (223-, 
ately  electroporated  using a Bio-Rad Gene  Pulser.  Electroporation  pa- 
rameters  were 260 V and  960  microFarrads by using the Bio-Rad ca- 
pacitance  extender.  After  electroporation the cells  were  transferred  to 
tissue  culture  flasks  containing  12  ml of media  and  incubated a t  37 "C 
for  48 h. 
Assay of CAT and 0-Galactosidase Activities-Forty-eight h after 
transfection the cells were harvested from tissue culture flasks and 
transferred  to  Eppendorftubes.  The cells were  washed  with  phosphate- 
buffered saline and resuspended in 250 m~ Tris-HC1, pH 8.0, at a 
density of lo6 celld25 p1. Cells  were  lysed by three  freeze-thaw cycles. 
The  samples  were  then  centrifuged,  and  30 pl of the  supernatant  was 
subsequently  used to  measure  0-galactosidase  activity by the method of 
Sambrook et al. (1989). The activity was expressed as OD,,, x 100 
extrapolated  to 1 h of reaction. 
CAT activity  in  the  supernatants  was  determined  after  heating for 10 
min at 65 "C (Crab and Dixon, 1987). Thirty pl of supernatant  was 
adjusted to 125  pl  with  addition of 0.25 M Tris-HC1, pH 8.0, 2.5 pl of 10 
mg/ml butyryl-CoA (Sigma) and 0.1 pCi of ['4Clchloramphenicol (52 
mCi/mmol, Dupont-New England Nuclear), and reactions were incu- 
bated at 37 "C. Depending  on the cell line  used the reaction  time  was 
varied  from  15  min  to 1 h to  keep  product  formation  in  the  linear  range. 
The reactions were terminated by adding 300 pl of xylene, and  the 
reaction  products  were  isolated by the  phase  extraction  procedure of 
Seed and  Sheen (1988). CAT activity  was  expressed as countdminutd 
hour of radioactive  butyrylated  chloramphenicol.  These  numbers  were 
then normalized for equal transfection efficiency within a given cell 
type by calculating  the CAT activity/100  units of P-galactosidase  activ- 
ity. The normalized data for a particular construct, for transfection 
experiments  conducted  on  different  days,  varied by 2-fold. Data for the 
CAT assays  were  expressed  as  the  mean 2 SD of four  to  seven  inde- 
pendent  transfection  experiments  using at least  two  different  plasmid 
preparations of the  same construct. 
Primer  Extension Analysis-Forty-eight h after  transfection  cells (5 x 
lo7 to 10') were  harvested,  and  total RNA was  isolated by the 
guanidiudCsC1  method  (Sambrook  et al., 1989).  For  primer  extension 
50 pg of total RNA was annealed to 32P-end-labeled oligonucleotide 
5'-GGGATATATCAATGGTATATC-3'. This oligonucleotide is comple- 
mentary  to  the CAT coding region  beginning 43  bp  downstream of the 
CAT translational start site. To anneal  primer  and  target RNA, samples 
were  heated for 8 min at 85 "C in  30 pl of annealing  buffer  (0.25 M KC], 
10 mM Tris-HC1, pH 8.0, and 1 mM EDTA) and  then  incubated for 60 min 
at 50 "C, followed by slow cooling for 15 min a t  room temperature.  After 
ethanol  precipitation  samples  were  resuspended  in  reverse  tran- 
scriptase  buffer (50 mM Tris-HC1, pH 8.0, 75 mM KC], 3 mM MgCl,, 10 
mM dithiothreitol)  and 0.5 mM deoxynucleotides. After  addition of 20 
units of RNASIN (Promega)  and 200 units Moloney murine  leukemia 
virus reverse  transcriptase  (BRL),  samples  were  incubated for 60  min 
at 37 "C. cDNA products  were  incubated  with 20 pg/ml  RNase (Ambion) 
for 30  min  and  then  treated  with  proteinase K before phenol-chloroform 
extraction  and  ethanol  precipitation.  Samples  were  analyzed on a 6% 
polyacrylamide, 8 M urea  denaturing  sequencing gel. Primer  extension 
cDNA products  were  visualized by autoradiography, and  the sizes of the 
products  were  determined by comparison  with  32P-end-labeled $X174/ 
Hue111 markers  and DNA sequencing  ladders. 
RESULTS 
Mapping of the Dunscription  Start  Site of the Human TdT 
GeneStandard  methods for determining the transcription 
start  site of the  human TdT gene were unsuccessful in  our 
hands since this gene is  transcribed at a very low rate in vivo. 
Therefore, we sought to identify the  transcription  start  site for 
the  human TdT gene by using  the powerful 5'-RACE technique. 
This highly sensitive  technique employs isolation of RNA, SF- 
thesis of cDNA, addition of C residues  to  the cDNA, amplifica- 
tion of the product by PCR, and sequencing of this product. To 
ensure  that  the  template  in  these reactions was RNA, a series 
of primers, each of which produced a different length of ampli- 
fied product was  used (Fig. lA). PCR products of the predicted 
size were observed when RNA from the TdT-positive cell line 
NALM-6 was used in  the reaction  (Fig. lB, lanes 1,2, and 5-71. 
The sizes of the PCR products  detected in each lane were con- 
sistent with a transcription start site of approximately 50-75 
bases 5' t o  the ATG translational start site. In contrast, RNA 
from the TdT-negative cell line KOPN-8 yielded no specific PCR 
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FIG. 1. Identification of the transcription  start  for  the human TdT gene by 5"RACE. A,  schematic illustration of 5'-RACE experiment 
to  the ATG at  +62  and  the  exonUexon2 boundary at  +265/+266. Primers for cDNA synthesis (RACES- and RACE4-) and PCR (RACE4-,  RACE3-, 
shown in B. The bold arrow pointing to  thc right represents transcribed Sequences from the +1 start  site  to nucleotide +367. Vertical arrows point 
225 ,223-  and anchor primer) are indicated by horizontal  arrows with their nucleotide location relative  to  the transcription start  site below each 
arrow. Dashed  lines represent  the PCR products shown in B .  A is an approximate line drawing. B, lanes 1 , 2 ,  and 5-7, represent TdT-positive 
NALM-6 PCR products. Lanes 3 , 4 , 8 ,  and 9 represent TdT-negative KOPN-8  PCR products. cDNA was  synthesized  with  the RACE5 antisense 
primer (lanes 1 4 )  or with RACE4- antisense primer (lanes 5-9). Antisense primers upstream from RACE5- (RACE4-, lanes 1 and 3 )  or  upstream 
of RACE4- (RACE3-, lanes 2 , 4 ,  and 5; 2 2 5 ,  lanes 6 and 8; 223-, lanes 7 and 9) were used as internal antisense primers for PCR. Some background 
was observed after  using  the  223- primer (lanes 6 and 8). Lanes 10-14 were negative control 5'-RACE reactions. Lane 10, TdT sense primer with 
NALM-6 RNA. Lane 11, C residues were not added to the cDNA. Lunes 12-14, no cDNA was  used  in  the PCR. 
products in  this  experiment (Fig. lB, lanes 3,4,8,  and 9) .  The 
precise transcription start site (a T) at 62  bp 5' upstream of 
ATG was  determined by cloning and  sequencing one of the PCR 
products. 
To confirm the size of the 5' non-translated region of the 
RNA, another  experiment  was performed. "P-End-labeled oli- 
gonucleotides  complementary to sequences upstream  or down- 
stream of the  putative  transcription start site were  hybridized 
to mRNA from TdT-positive cells by using  Northern  analysis. 
These  experiments showed that oligonucleotides antisense  to 
mRNA sequences downstream  but  not  to DNA sequences up- 
stream of the proposed transcription  start  site hybridized to  the 
RNA and were detected on the  Northern blots (data  not shown). 
Functional Analysis of the 5'-Flanking Sequence of the Hu- 
man TdT Gene-In this  study we sought  to  establish a func- 
tional  assay for potential promoter elements  in  the 5' upstream 
region of the human TdT gene. This region was sequenced 
when the  gene  was cloned (Riley et al., 1988).  Within 995 bp 
upstream from the translation start site ATG, a number of 
known transcription factor-binding sites were present (Fig. 2). 
AP2-binding sites were  identified in  the regions -55 to -62 and 
+33 to +41. There  was  an  Ets-binding  site at -101 to -95 which 
in  the  murine  TdT  gene  has been shown  to be essential for 
transcription  (Ernst et al., 1993). There were several  binding 
sites for INF-1, a binding  site for Oct-1, and a TATA box. In 
order  to  test  the function of these  elements in  vivo, a transient 
transfection  assay  was developed. 
The cells we elected to  use for these  experiments were un- 
differentiated lymphoblastoid  cells that  were well established 
in  continuous  suspension cell culture.  The TdT-positive lines 
used were MOLT-4,  NALM-6, and KT-1 cells. The TdT-negative 
lymphoblastoid line  was WE-37. These  permanent cell lines  are 
the only source for TdT expression  (Drexler et al.,  1985)  and  are 
highly resistant  to  transfection (Lo et al., 1991). 
Calcium phosphate, DEAE-dextran, and lipofection transfec- 
tion protocols failed to promote efficient transfer of control plas- 
mids. By contrast, efficient transfection of all cell lines was 
obtained by electroporation following optimization of the  den- 
sity of the cells at the  time of harvest,  the cell concentration, 
buffer composition of the cell suspension  to be electroporated, 
and the temperature a t  which the cell suspension was kept 
prior  to electroporation. 
Using  the optimized  electroporation protocol, a series of  CAT 
constructs containing various lengths of the 5'-flanking se- 
quences of the  human  TdT  gene  was  transiently  transfected 
into  the KT-1, MOLT-4, or NALM-6 cells (TdT expressing)  or 
the KE-37 (TdT non-expressing) cells. The CAT activity  was 
measured 48-h post-transfection. CAT activities were  corrected 
for transfection efficiencies by cotransfecting the cells with 
pCMVp DNA and  normalizing  the CAT activityh00  units of 
/%galactosidase activity. The results from the first series of 
constructs  are shown in Fig. 3. Identical  data were observed 
with all three positive cell lines, but for simplicity, only the 
results  obtained  with KT-1 cells are  illustrated  in  the figure. 
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FIG. 2. Nucleotide  sequence of the  5”flanking  region  and  part 
of exon 1 of the human TdT gene. The transcription initiation site is 
marked as +l .  Primers used  to generate deletion constructs are indi- 
cated by arrows above and below the sequences. The BamHI, EcoRI, 
and AccI sites are marked. The putative binding regions, based on 
sequence analysis for well established transcription factors are under- 
lined. 
The pattern of expression of CAT activity, varied in TdT- 
positive (KT-1) and TdT-negative (KE-37) lymphoblastoid cells 
(Fig. 3). In both cell types  the regions  54 and 34 bp  upstream 
from the  transcription  start  site (-54CAT) and (-34CAT) were 
capable of directing maximum CAT synthesis in cells. This 
activity was  assigned a value of loo%, which corresponded to 
400 pmol of product  when KT-1 cell extracts were used  in  the 
CAT assays  and 500 pmol when KE-37 cell extracts were  used. 
The CAT activity  obtained with cells transfected  with  the  other 
constructs were  scaled to  these optimal  activities. 
Elongation of the 5‘ upstream sequence beyond -54 dimin- 
ished CAT gene  expression in both cell types (Fig. 3). However, 
a differential inhibition of transcription was observed. The 
plasmid constructs -93OCAT and -656CAT exhibited no pro- 
moter  activity over the basic vector (pCAT-Enhancer) alone in 
KT-1 cells whereas  in KE-37 both of these  constructs showed 
promoter  activity that  was 25-30%  of that observed with  the 
-34CAT construct. Likewise, the -356CAT and -202CAT  con- 
structs exhibited  detectable CAT activity in  the KT-1 cells al- 
though  it  was consistently lower than  in KE-37 cells. 
When 29 additional  bases were removed from the -34CAT 
plasmid to form the -5CAT construct, CAT expression was  still 
obtained. However, the level was reduced  compared with 
-34CAT, and  the reduction was more severe in  the TdT-positive 
than  in  the TdT-negative cell line. Deletion of bases  past  the 
transcription start site (+41CAT and exon-1CAT) abolished all 
promoter  activity in both cell types. The -286CAT(R) construct 
in which the  5”flanking region was cloned in  the  reverse ori- 
entation elicited CAT activity  comparable to  the  same construct 
in  the correct orientation. 
Detailed analyses of the region around the transcription 
start site revealed that 50% of maximum CAT activity was 
obtained with the sequences spanning +25 to ATG (Fig. 4). 
Deletion of the region +25 to ATG (i.e. the -54 to  +25CAT 
construct) did  not  abolish CAT activity indicating  that  the -54 
to +25 region had promoter activity but did not retain the 
optimal activity associated with -54CAT. Thus the sequence 
from +25 to +40  was  necessary but not  sufficient for optimal 
transcription. 
Results identical to those in Figs. 3 and 4 were obtained 
when constructs containing pCAT-Basic vectors which lack the 
SV40 enhancer region were transfected into lymphoid cells 
(data  not shown). Determination of the effect of the SV40 en- 
hancer on transcription efficiency in  this  system  was  thus pre- 
cluded. 
To test TdT  promoter  activity in non-lymphoid cells, all  the 
pCAT-Enhancer TdT constructs were transfected into Hela 
cells. However, a high  background level of transcription was 
observed in  these cells that  masked  the effects of the various 
TdT  gene  constructs. Thus, Hela  cells  were  not used as a non- 
lymphoid control for transfection experiments. 
Primer Extension Analysis of RNA Isolated  from  Dansfected 
Cells-To confirm that reaction products measured by CAT 
activity assays,  initiated at the TdT transcription start, primer 
extension analysis  was  carried  out on RNA isolated from trans- 
fected cells. The  results of two representative  experiments  are 
shown in Fig. 5. KE-37 and KT-1 cells were transfected  with  the 
constructs -54CAT (Fig. 5 ,  lanes 2, 5, 7 ,  and 9), +25CAT (Fig. 
5 ,  lanes 3 and 6), and -54 to +25CAT (Fig. 5 ,  lanes 8 and 10). 
The control DNA in  these  experiments  was  the basic vector 
pCAT-Enhancer (Fig. 5 ,  lanes 1 and 4). The RNA employed in 
the  primer extension  reaction  was  isolated from cells after 48  h 
in  culture.  The predicted cDNA reaction  product from -54CAT 
was 171  bp long. The vector sequence  contributed  109  bp, and 
the  transcription  start  was expected to  be at about 62 bp from 
the  translation start site. A  major band was visible correspond- 
ing  to 70 bp from the ATG when primer extension analysis  was 
done on RNA isolated  from -54CAT-transfected cells. This site 
mapped closely (8 bases longer) to  the  transcription start site 
determined by 5’-RACE (Fig. 1) and by in vitro transcription 
assay (data not shown). The difference in the transcription 
start site is probably due to technical details of the assays. 
Manipulation of the TdT mRNA during  the 5’-RACE procedure 
could easily result  in loss of a few bases.  Alternatively, the sizes 
of the cDNA products measured  after  primer extension could be 
slightly inaccurate  due to lane  to  lane variability in  the elec- 
trophoresis procedure. The doublet observed at  the major start 
site  might  represent  transcription  initiation at either of two 
bases. Alternatively, the doublet is  an  artifact of the  primer 
extension reaction. A faint  band (at least 4-fold less  intense 
than  the major band)  was also observed at  42 bp upstream from 
ATG when -54CAT was used as the  transfecting DNA. Both of 
these major and minor bands were consistently absent in 
analyses of RNA isolated from cells transfected with the 
+25CAT construct. This  result suggested that sequences up- 
stream from the  start  site  and  surrounding  the start site were 
important for correct initiation of transcription. 
The construct  containing  sequences spanning -54 to  +25  was 
found to initiate  transcription accurately  since a cDNA product 
of the expected size (131 bp) was observed after transfection of 
this DNA construct  into KT-1 and KE-37 cells (Fig. 5 ,  lanes 8 
and 10). These  data indicated that  accurate  transcription could 
occur when only two parts of the  basal promoter  were present. 
The  primer extension analysis of  CAT mRNA from transfected 
cells coupled with  the  results of the CAT assay (Fig. 4)  sug- 
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FIG. 3. Functional analysis of the  S’-flanking  sequence of the  human  TdT gene. The l ine diagram on the left of the figure represents the 
deletion TdT constructs used in  transient transfection assays. Open boxes represent exon-1 sequence, and solid bores represent CAT coding 
sequences. Nucleotide positions with respect to +1  as the transcription start site  are indicated above the line. CAT and P-galactosidase  enzyme 
activities were measured in KT-1 and KE-37 cell lines transfected with 35 pg of the TdT deletion construct DNAs and 5 pg of pCMVP  DNA as 
described under “Materials and Methods.” The CAT activity of the -34 CAT construct was assigned a value of 100%. This represents 400 pmol of 
butyrylated chloramphenicol in KT-1 cells and 500 pmol in KE-37 cells. Data are mean values from four to seven experiments. At least two different 
plasmid preparations were used for each transfection assay. 
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FIG. 4. Functional analysis of sequences  downstream of the  transcription  start site. The line diagram on the left of the figure represents 
the deletion TdT constructs used in  transient transfection assays. Open bores represent exon-1  sequence, and solid bores represent CAT coding 
sequences. Nucleotide positions with respect to +1 as the transcription start site are indicated above the line. Shown are the relative CAT activities 
of  -54CAT,  +25CAT,  -54 to +25CAT, and +41CAT in KT-1 and KE-37 cells. aansfection procedures were carried out as described in Fig. 3 and under 
“Materials and Methods.” 
gested  that  all  three  segments of the promoter (the  primary 
element  within -34 bp, the  element  spanning  the  transcription 
start site and the downstream element) were necessary for 
optimal  promoter activity. 
DISCUSSION 
An important  step  in identification of promoter elements is 
an  accurate positioning of transcription start. Previously, Koi- 
wai and Morita (1988) had identified two transcription start 
sites for the  human TdT  gene, at 80 and at 106 bp upstream 
from the ATG. However, our in vivo experiments (5’-RACE 
technique) consistently  identified a single start site at 62 bp 
upstream from translation start. While the reasons for the 
discrepancy are  not  clear  the transfection experiments  support 
the  site we identified. 
The  human TdT  gene lacks TATA and CAAT consensus se- 
quences  immediately 5’ to the  initiation  site, a characteristic 
that is shared by other eukaryotic  genes. The  5”flanking se- 
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RNA derived from  TdT-CAT DNA- 
FIG. 5. Primer extension analysis of 
transfected cells. Primer  extension  re- 
actions  were  performed on 50 pg of total 
RNA isolated from KE-37 and KT-1 cells 
transfected with 35 pg of the indicated 
plasmid DNA. 5'-end-labeled oligonucle- 
otide complementary to the CAT coding 
region ("Materials  and  Methods")  was 
used for primer  extension.  The cDNA re- 
action  products  were  electrophoresed  on  a 
denaturing  gel,  and  the  products  were vis- 
ualized by autoradiography.  In  lanes 1-6, 
the upper arrow indicates the predicted 
+1 transcription start  site,  and  the lower 
arrow  indicates a minor  transcription 
start  site. The control lune contains the 
primer  extension  data  with 50 pg of RNA 
isolated from cells  transfected  with pCAT- 
Enhancer.  Lanes 7-10 were from another 
experiment. The upper arrow and lower 
arrow in lanes 7-10 both indicate the 
predicated +1 transcription start  site.  The 
cDNA products  in  lanes 8 and 10 were  40 
bp shorter than those in lunes 7 and 9 
because of the deletion of sequences  from 
+25 to ATG during  cloning of the -54 to 
+25CAT construct.  H eIII-digested 
0x174 size markers (R'P-labeled) are 
shown on the left  side of each  panel.  The 
dashes, -, on  the  left of the figure  corre- 
spond  to the  bands  in  the  marker  lane  and 
represent 281, 271, 234, 194, and 118 
bases, respectively. 
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quences of the human and mouse TdT genes share limited 
homology. The mouse TdT  gene  was difficult to  study because 
transcription  rates of this  gene were very low (Smale  and Bal- 
timore, 1989; Lo et al., 1991). No CAT activity was detected 
when TdTCAT fusion plasmids were used for transfections of 
mouse  lymphoma cells (Lo et al., 1991).  Therefore, to identify 
regulatory  elements,  Smale  and co-workers resorted  to  the  use 
of replicating vectors in  transient  transfection  assays (Lo et al., 
1991; Ernst et al., 1993). However, the  authors of that  study 
suggested replicating vectors probably masked all but the 
strongest control elements. We initially confronted a similar 
problem in  our  study of the  human  TdT gene. Transient  trans- 
fection assays using CAT reporter vectors fused to different 
regions of the human TdT gene were difficult to establish. 
However, optimizing conditions for electroporation helped to 
increase the transfection efficiency and made these experi- 
ments feasible. 
With transient transfection assays of immature lymphoid 
cells firmly established, we tested a series of TdTCAT fusion 
genes  in  transfection  assays.  The  optimal levels of CAT activity 
were  consistently observed when  the sequence spanning -541 
-34 to ATG was used in  transfection  assays.  Further  analyses 
identified the  basal promoter of the  human  TdT  gene  within 
the region -34 to +40 bp. Moreover, three  distinct control  ele- 
ments  in  this region were  identified. The  first control element 
was located 34 bp upstream from the  transcription start site, 
but we have  not  yet  determined  its precise boundaries. Nega- 
tive  regulation  was also evident  upstream from -54 bp. This 
transcription inhibition effect was  far more prominent  in TdT- 
positive than in TdT-negative cell lines. In fact, when the 
KT-1 
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-93OCAT and -656CAT  DNA were used  to  transfect KT-1 cells, 
virtually no CAT activity was detected. The  same  constructs 
yielded 25 times more CAT activity in TdT-negative than  in 
TdT-positive cells. With the construct -356CAT, three times 
more CAT activity was  detected  in TdT-negative than  in TdT- 
positive cells. These  results  suggest  that  negative  regulatory 
element  exists  in  the region -356 to -656 and  that  it  is differ- 
entially active in  the TdT-positive cells. Inspection of the 5' 
sequence for putative  transcription factor-binding sites  identi- 
fied potential M 1 ,  INF-1, NF-1, and Oct-1 elements in this 
region (-356 to -656). Any one of these  or a different protein 
binding  within  this region could possibly exert a negative effect 
on TdT  transcription  in TdT-positive cells. The sequences be- 
tween -54 to -356 also  exerted  negative  regulation,  and  the 
effect was roughly equivalent  in both KT-1 and Kl3-37 cells. A 
variety of negative  elements,  in different gene  promoters  has 
been characterized  (Baniahmad et al., 1987; Wang and  Brand, 
1990; Rincon-Limas et al., 1991). The  exact position and  nature 
of the  negative  elements  in  human  TdT 5' sequences will be the 
subject of further  investigation. 
The second of the  three  elements  within  the  human  basal 
promoter was found to  span  the  transcription  start  site. When 
a construct  was used that contained only 5 bp upstream from 
the  transcription  start  site along with  downstream sequences 
to  the ATG, CAT activity was  readily  detected  although a t  a 
reduced level. Furthermore, no specific transcripts were ob- 
served  in  primer extension experiments  when sequences  both 
upstream  and  around  the  start  site wer  removed. The fact that 
this  construct (-5CAT) was  able  to drive CAT activity, and  that 
transcription in vivo initiated a t  a single nucleotide in the 
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absence of a TATA sequence indicated that  an  Inr type element 
was present in  the  human promoter sequence (Weis and Rein- 
berg, 1992;  Kollmar and  Farnham, 1993). There was no visible 
homology between the human TdT initiation site and the 
mouse  TdT Inr element, but we did  observe a similarity to an 
8-bp Inr consensus sequence (GCAGTCTC) described by  Koll- 
mar  and  Farnham (1993). In order to match the  Inr homology 
to our human TdT sequence, we had to place the  start site at  an 
A (as described in Kollmar and  Farnham, 1993) two nucleotides 
upstream from the T  initiation  site detected by 5'-RACE. 
The third promoter element spanned nucleotides +25 to +40. 
This element alone was not capable of initiating  transcription 
correctly. Primer extension analyses of the transcription prod- 
ucts indicated that initiation was no longer at a single nucle- 
otide when only the  third promoter element was contained in 
the constructs. However,  removal of this sequence in  the CAT 
constructs resulted  in  a 2-fold reduction in CAT activity in the 
transfection assay when  compared with the complete basal pro- 
moter. This reduction was significant since the decrease repre- 
sented  a drop from about 500 to 250  pmol of butyrylated prod- 
uct. There are several examples of downstream regulatory 
elements in other genes. The SV40 major late promoter re- 
quires for correct initiation of transcription, sequences centered 
28  bp downstream of the CAP site (Ayer and Dynan, 1988). In 
the HIV promoter sequences spanning +21 to +30 enhances 
transcription (Zenzie-Gregory et al., 1993). The exact mecha- 
nism by which the downstream element in the human TdT 
promoter affects transcription is still not understood, but is 
under investigation. 
Another feature of the  human TdT basal promoter was its 
bidirectional activity.  While not common, bidirectional activity 
of promoters is not without precedence (Abrams and Schimke, 
1989;  Rincon-Limas et al., 1991). 
The proteins responsible for basal promoter activity of the 
human TdT gene have not yet been clearly identified. Gel  mo- 
bility shift assays  and DNase I footprinting analyses with vari- 
ous regions of the basal promoter have detected specific protein 
binding to the sequences -27 to  -17,  -17 to -6 and +25 to +40 
(data not shown). Further experiments are underway to iden- 
tify these proteins and to assess exactly how they function in 
transcription of the  human TdT  gene. 
In summary, we have demonstrated that  the human TdT 
gene contains a  basal promoter that functions comparably in 
both TdT expressing and non-expressing cells. The basal pro- 
moter of the human TdT gene is not identical to that found in 
the murine TdT  gene. The latter seems to consist only of an Inr 
element. In addition, an LyF-1 and an  Ets sequence upstream 
from the  Inr seems to provide  lymphoid  specificity to  the mouse 
TdT gene. In contrast, the  human TdT basal promoter consists 
of three elements, including a consensus Inr element. While 
LyF-1- and Ets-binding sites  are present upstream from the 
human basal promoter (Lo et al., 1991; Ernst et al., 1993), 
participation of these two proteins in lymphoid-specific tran- 
scription of the human TdT gene is not apparent from the 
experiments we have performed since these sequences had no 
detectable effect  on CAT activity. 
Studies of the boundaries of the  basal promoter, negative 
regulatory elements, and tissue-specific enhancer elements in 
other regions of the  human gene are currently underway in our 
laboratory. These results will help us understand transcrip- 
tional regulation of the human TdT  gene and will help define 
the various mechanisms by which tissue-  and differentiation- 
specific  gene expression is controlled. 
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